Column Group Iii Gp, Lp - Net Worth and Insider Trading
Column Group Iii Gp, Lp Net Worth
The estimated net worth of Column Group Iii Gp, Lp is at least $43 Million dollars as of 2024-12-27. Column Group Iii Gp, Lp is the 10% Owner of Tenaya Therapeutics Inc and owns about 22,999,565 shares of Tenaya Therapeutics Inc (TNYA) stock worth over $34 Million. Column Group Iii Gp, Lp is also the 10% Owner of Surrozen Inc and owns about 627,652 shares of Surrozen Inc (SRZN) stock worth over $9 Million. Details can be seen in Column Group Iii Gp, Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Column Group Iii Gp, Lp has not made any transactions after 2024-04-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Column Group Iii Gp, Lp
Column Group Iii Gp, Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Column Group Iii Gp, Lp owns 6 companies in total, including NGM Biopharmaceuticals Inc (NGM) , Revolution Medicines Inc (RVMD) , and Constellation Pharmaceuticals Inc (CNST) among others .
Click here to see the complete history of Column Group Iii Gp, Lp’s form 4 insider trades.
Insider Ownership Summary of Column Group Iii Gp, Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NGM | NGM Biopharmaceuticals Inc | 2019-10-14 | 10 percent owner & other: General Partner |
| RVMD | Revolution Medicines Inc | 2020-11-16 | 10 percent owner |
| CNST | Constellation Pharmaceuticals Inc | 2020-03-19 | 10 percent owner & other: General Partner |
 | | 2024-04-04 | 10 percent owner |
| | 2024-02-12 | 10 percent owner |
| | 2021-08-11 | 10 percent owner |
Column Group Iii Gp, Lp Latest Holdings Summary
Column Group Iii Gp, Lp currently owns a total of 2 stocks. Among these stocks, Column Group Iii Gp, Lp owns 22,999,565 shares of Tenaya Therapeutics Inc (TNYA) as of February 12, 2024, with a value of $34 Million and a weighting of 79.82%. Column Group Iii Gp, Lp also owns 627,652 shares of Surrozen Inc (SRZN) as of April 4, 2024, with a value of $9 Million and a weighting of 20.18%.
Latest Holdings of Column Group Iii Gp, Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TNYA | Tenaya Therapeutics Inc | 2024-02-12 | 22,999,565 | 1.50 | 34,499,348 |
| SRZN | Surrozen Inc | 2024-04-04 | 627,652 | 13.90 | 8,724,363 |
Holding Weightings of Column Group Iii Gp, Lp
Column Group Iii Gp, Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Column Group Iii Gp, Lp has made a total of 6 transactions in Tenaya Therapeutics Inc (TNYA) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Tenaya Therapeutics Inc is the acquisition of 2,222,222 shares on February 12, 2024, which cost Column Group Iii Gp, Lp around $10 Million.
According to the SEC Form 4 filings, Column Group Iii Gp, Lp has made a total of 2 transactions in Surrozen Inc (SRZN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Surrozen Inc is the acquisition of 193,548 shares on April 4, 2024, which cost Column Group Iii Gp, Lp around $3 Million.
Insider Trading History of Column Group Iii Gp, Lp
- 1
Column Group Iii Gp, Lp Trading Performance
GuruFocus tracks the stock performance after each of Column Group Iii Gp, Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Column Group Iii Gp, Lp is 46.48%. GuruFocus also compares Column Group Iii Gp, Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Column Group Iii Gp, Lp within 3 months outperforms 5 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Column Group Iii Gp, Lp's insider trading performs compared to the benchmark.
Performance of Column Group Iii Gp, Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.2 | | | | | |
| Relative Return to S&P 500(%) | 2.66 | | | | | |
Column Group Iii Gp, Lp Ownership Network
Column Group Iii Gp, Lp Owned Company Details
What does NGM Biopharmaceuticals Inc do?
Who are the key executives at NGM Biopharmaceuticals Inc?
Column Group Iii Gp, Lp is the 10 percent owner & other: General Partner of NGM Biopharmaceuticals Inc. Other key executives at NGM Biopharmaceuticals Inc include director & 10 percent owner David V Goeddel , 10 percent owner Column Group L P , and Chief Financial Officer Jean-frederic Viret .
NGM Biopharmaceuticals Inc (NGM) Insider Trades Summary
Over the past 18 months, Column Group Iii Gp, Lp made no insider transaction in NGM Biopharmaceuticals Inc (NGM). Other recent insider transactions involving NGM Biopharmaceuticals Inc (NGM) include a net purchase of 67,893 shares made by Column Group L P , and a net purchase of 26,811 shares made by David V Goeddel .
In summary, during the past 3 months, insiders sold 0 shares of NGM Biopharmaceuticals Inc (NGM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NGM Biopharmaceuticals Inc (NGM) were sold and 94,704 shares were bought by its insiders, resulting in a net purchase of 94,704 shares.
NGM Biopharmaceuticals Inc (NGM)'s detailed insider trading history can be found in Insider Trading Tracker table.
NGM Biopharmaceuticals Inc Insider Transactions
Column Group Iii Gp, Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Column Group Iii Gp, Lp. You might contact Column Group Iii Gp, Lp via mailing address: 1700 Owens Street, Suite 500, San Francisco Ca 94158.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
